Purpose: The aim of this study is to examine and compare with the validated, paper/pencil European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy Scale (QLQ-CIPN20), the psychometric properties of three electronically administered patient reported outcome (PRO) measures of chemotherapy-induced peripheral neuropathy (CIPN): (1) the two neuropathy items from the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), (2) the QLQ-CIPN20, and (3) the 0–10 Neuropathy Screening Question (NSQ). Methods: We employed a descriptive, cross-sectional design and recruited 25 women with breast cancer who wer...
Chemotherapy Induced Peripheral Neuropathy (CIPN) is a common problem among cancer patients who ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common phenomenon, often resulting in serious...
Abstract Background In an evaluation of chemotherapy-induced peripheral neuropathy (CIPN), objectivi...
Chemotherapy induced peripheral neuropathy (CIPN) is a common side effect of several chemotherapy dr...
PURPOSE: Up to 40% of cancer patients treated with neurotoxic chemotherapies experience chemotherapy...
Chemotherapy induced peripheral neuropathy (CIPN) is a common side effect of several chemotherapy dr...
Abstract Background Timely detection of chemotherapy-...
Purpose: This clinimetric analysis was conducted to evaluate the reliability, validity, and responsi...
Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting complication o...
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting co...
SummaryPurposeThis cross-sectional study aimed at determining the relationship between patient-repor...
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially reversible si...
Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity...
Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major and potentially dose-limiting adverse e...
Chemotherapy Induced Peripheral Neuropathy (CIPN) is a common problem among cancer patients who ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common phenomenon, often resulting in serious...
Abstract Background In an evaluation of chemotherapy-induced peripheral neuropathy (CIPN), objectivi...
Chemotherapy induced peripheral neuropathy (CIPN) is a common side effect of several chemotherapy dr...
PURPOSE: Up to 40% of cancer patients treated with neurotoxic chemotherapies experience chemotherapy...
Chemotherapy induced peripheral neuropathy (CIPN) is a common side effect of several chemotherapy dr...
Abstract Background Timely detection of chemotherapy-...
Purpose: This clinimetric analysis was conducted to evaluate the reliability, validity, and responsi...
Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting complication o...
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting co...
SummaryPurposeThis cross-sectional study aimed at determining the relationship between patient-repor...
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially reversible si...
Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity...
Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major and potentially dose-limiting adverse e...
Chemotherapy Induced Peripheral Neuropathy (CIPN) is a common problem among cancer patients who ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common phenomenon, often resulting in serious...
Abstract Background In an evaluation of chemotherapy-induced peripheral neuropathy (CIPN), objectivi...